ALIGN TECHNOLOGY, INC. Goodwill, Foreign Currency Translation Gain (Loss)
ALIGN TECHNOLOGY, INC. (ALGN) reported Goodwill, Foreign Currency Translation Gain (Loss) of -$13.12 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Other Income
us-gaap:GoodwillForeignCurrencyTranslationGainLoss · last filed 2026-08-05
- ALIGN TECHNOLOGY, INC. goodwill, foreign currency translation gain (loss) for the quarter ending 2026-06-30 was -$5.74M, a 117.14% decline year-over-year.
- ALIGN TECHNOLOGY, INC. goodwill, foreign currency translation gain (loss) for the quarter ending 2026-03-31 was -$7.38M, a 149.29% decline year-over-year.
- ALIGN TECHNOLOGY, INC. goodwill, foreign currency translation gain (loss) for the quarter ending 2025-12-31 was $317.00K.
- ALIGN TECHNOLOGY, INC. goodwill, foreign currency translation gain (loss) for the quarter ending 2025-09-30 was $444.00K, a 97.41% decline year-over-year.
- ALIGN TECHNOLOGY, INC. goodwill, foreign currency translation gain (loss) for fiscal 2025 was $49.20M.
- ALIGN TECHNOLOGY, INC. goodwill, foreign currency translation gain (loss) for fiscal 2024 was -$24.48M, a 304.32% decline from fiscal 2023.
- ALIGN TECHNOLOGY, INC. goodwill, foreign currency translation gain (loss) for fiscal 2023 was $11.98M.
- ALIGN TECHNOLOGY, INC. goodwill, foreign currency translation gain (loss) for fiscal 2022 was -$19.73M.
| Period end | Goodwill, Foreign Currency Translation Gain (Loss) 3 month | Goodwill, Foreign Currency Translation Gain (Loss) 6 month | Goodwill, Foreign Currency Translation Gain (Loss) 9 month | Goodwill, Foreign Currency Translation Gain (Loss) 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$5.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$13.12M 10-Q · filed 2026-08-05 | -$12.80M derived: sum of 3 quarters · filed 2026-08-05 | -$12.36M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$7.38M 10-Q · filed 2026-05-06 | -$7.07M derived: sum of 2 quarters · filed 2026-05-06 | -$6.62M derived: sum of 3 quarters · filed 2026-05-06 | $26.84M derived: sum of 4 quarters · filed 2026-05-06 |
| 2025-12-31 | $317.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $761.00K derived: sum of 2 quarters · filed 2026-02-27 | $34.22M derived: sum of 3 quarters · filed 2026-02-27 | $49.20M 10-K · filed 2026-02-27 |
| 2025-09-30 | $444.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $33.91M derived: sum of 2 quarters · filed 2025-11-05 | $48.89M 10-Q · filed 2025-11-05 | $20.00M derived: sum of 4 quarters · filed 2026-02-27 |
| 2025-06-30 | $33.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $48.44M 10-Q · filed 2025-08-06 | $19.56M derived: sum of 3 quarters · filed 2026-02-27 | $36.68M derived: sum of 4 quarters · filed 2026-02-27 |
| 2025-03-31 | $14.98M 10-Q · filed 2025-05-08 | -$13.90M derived: sum of 2 quarters · filed 2026-02-27 | $3.21M derived: sum of 3 quarters · filed 2026-02-27 | -$527.00K derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-12-31 | -$28.88M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$11.77M derived: sum of 2 quarters · filed 2026-02-27 | -$15.51M derived: sum of 3 quarters · filed 2026-02-27 | -$24.48M 10-K · filed 2026-02-27 |
| 2024-09-30 | $17.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $13.37M derived: sum of 2 quarters · filed 2024-11-05 | $4.41M 10-Q · filed 2024-11-05 | $19.64M derived: sum of 4 quarters · filed 2025-02-28 |
| 2024-06-30 | -$3.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | -$12.71M 10-Q · filed 2024-08-02 | $2.52M derived: sum of 3 quarters · filed 2025-02-28 | -$7.95M derived: sum of 4 quarters · filed 2025-02-28 |
| 2024-03-31 | -$8.97M 10-Q · filed 2024-05-03 | $6.27M derived: sum of 2 quarters · filed 2025-02-28 | -$4.20M derived: sum of 3 quarters · filed 2025-02-28 | -$3.66M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-12-31 | $15.23M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $4.76M derived: sum of 2 quarters · filed 2025-02-28 | $5.31M derived: sum of 3 quarters · filed 2025-02-28 | $11.98M 10-K · filed 2025-02-28 |
| 2023-09-30 | -$10.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | -$9.93M derived: sum of 2 quarters · filed 2023-11-03 | -$3.26M 10-Q · filed 2023-11-03 | $26.68M derived: sum of 4 quarters · filed 2024-02-28 |
| 2023-06-30 | $543.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $7.21M 10-Q · filed 2023-08-04 | $37.15M derived: sum of 3 quarters · filed 2024-02-28 | $15.94M derived: sum of 4 quarters · filed 2024-02-28 |
| 2023-03-31 | $6.67M 10-Q · filed 2023-05-05 | $36.61M derived: sum of 2 quarters · filed 2024-02-28 | $15.39M derived: sum of 3 quarters · filed 2024-02-28 | -$6.47M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-12-31 | $29.93M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $8.72M derived: sum of 2 quarters · filed 2024-02-28 | -$13.14M derived: sum of 3 quarters · filed 2024-02-28 | -$19.73M 10-K · filed 2024-02-28 |
| 2022-09-30 | -$21.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | -$43.08M derived: sum of 2 quarters · filed 2022-11-04 | -$49.66M 10-Q · filed 2022-11-04 | -$57.71M derived: sum of 4 quarters · filed 2023-02-27 |
| 2022-06-30 | -$21.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$28.45M 10-Q · filed 2022-08-04 | -$36.49M derived: sum of 3 quarters · filed 2023-02-27 | -$45.73M derived: sum of 4 quarters · filed 2023-02-27 |
| 2022-03-31 | -$6.58M 10-Q · filed 2022-05-05 | -$14.63M derived: sum of 2 quarters · filed 2023-02-27 | -$23.86M derived: sum of 3 quarters · filed 2023-02-27 | -$19.24M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-12-31 | -$8.05M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | -$17.28M derived: sum of 2 quarters · filed 2023-02-27 | -$12.66M derived: sum of 3 quarters · filed 2023-02-27 | -$29.92M 10-K · filed 2023-02-27 |
| 2021-09-30 | -$9.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | -$4.61M derived: sum of 2 quarters · filed 2021-11-02 | -$21.87M 10-Q · filed 2021-11-02 | -$4.39M derived: sum of 4 quarters · filed 2022-02-25 |
| 2021-06-30 | $4.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | -$12.64M 10-Q · filed 2021-08-04 | $4.84M derived: sum of 3 quarters · filed 2022-02-25 | |
| 2021-03-31 | -$17.26M 10-Q · filed 2021-05-05 | $219.00K derived: sum of 2 quarters · filed 2022-02-25 | ||
| 2020-12-31 | $17.48M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $40.71M 10-K · filed 2022-02-25 | ||
| 2020-09-30 | $23.24M 10-Q · filed 2020-10-30 | |||
| 2019-12-31 | -$105.00K 10-K · filed 2021-02-26 | |||
| 2018-12-31 | -$585.00K 10-K · filed 2020-02-28 | |||
| 2017-12-31 | $323.00K 10-K · filed 2019-02-28 | |||
| 2016-12-31 | -$30.00K 10-K · filed 2018-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |